New Data Reinforces Dupilumab’s Efficacy in Eosinophilic Esophagitis Treatment
New findings presented at the American College of Gastroenterology (ACG) 2025 Annual Scientific Meeting have strengthened the role of dupilumab (Dupixent) in managing eosinophilic esophagitis (EoE). The data highlight significant…